Movano (NASDAQ:MOVE) Stock Price Passes Above 200-Day Moving Average – Here’s What Happened

Movano Inc. (NASDAQ:MOVE)’s share price passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $8.71 and traded as high as $10.95. Movano shares last traded at $10.07, with a volume of 13,936 shares.

Key Headlines Impacting Movano

Here are the key news stories impacting Movano this week:

• Positive Sentiment: Faster-than-expected adoption of AI in healthcare could raise demand for remote-monitoring and AI-enabled diagnostic devices, a potential tailwind for Movano’s clinical and consumer wearable roadmap. The Medical School Dean Who Says AI in Healthcare Moved Faster Than He Ever Expected
• Neutral Sentiment: Broader AI/automation market trends (e.g., acceleration in AI service robotics) point to rising investor interest in AI-enabled devices, but robotics growth is not a direct proxy for demand for health wearables—so impact on Movano is possible but indirect. AI Service Robotics Market Accelerates as Platforms Move From Prototype to Revenue Deployment
• Neutral Sentiment: Elevated options/earnings-week volatility for AI and tech names increases market noise; Movano’s small market cap and limited liquidity mean sector volatility can move the stock even without company-specific news. Options Volatility and Implied Earnings Moves This Week, February 23 – February 26, 2026
• Neutral Sentiment: Low intraday trading volume today (well below the stock’s average) increases price sensitivity: when few shares change hands, modest orders can produce outsized moves in either direction.
• Negative Sentiment: Broader market weakness (tariff news and index volatility) is pressuring small caps and growth/AI-adjacent names; macro-driven risk-off likely contributed to Movano’s decline today. Stock Market Today: Dow Dives As EU Makes Trump Tariff Move; Novo Plunges On This (Live Coverage)
• Negative Sentiment: Movano’s very small market capitalization and thin liquidity make it more vulnerable to headline-driven swings and reduce institutional interest until more consistent revenue/profitability or clinical validation is visible.

Wall Street Analyst Weigh In

MOVE has been the topic of a number of analyst reports. Wall Street Zen downgraded shares of Movano from a “hold” rating to a “sell” rating in a research report on Sunday, February 15th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Movano in a report on Thursday, January 22nd. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock currently has a consensus rating of “Sell”.

Movano Trading Down 7.5%

The company’s 50-day moving average is $10.52 and its 200 day moving average is $8.71. The stock has a market capitalization of $11.48 million, a PE ratio of -0.93 and a beta of 0.80.

Insider Transactions at Movano

In related news, CTO Michael Aaron Leabman sold 6,845 shares of the firm’s stock in a transaction on Wednesday, January 14th. The stock was sold at an average price of $6.66, for a total value of $45,587.70. Following the completion of the transaction, the chief technology officer owned 22,639 shares in the company, valued at $150,775.74. This trade represents a 23.22% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, CFO Jeremy Cogan sold 28,736 shares of the business’s stock in a transaction dated Tuesday, January 27th. The shares were sold at an average price of $20.78, for a total value of $597,134.08. Following the sale, the chief financial officer owned 60,504 shares in the company, valued at approximately $1,257,273.12. The trade was a 32.20% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders sold 94,383 shares of company stock worth $1,524,933. Company insiders own 10.40% of the company’s stock.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Movano stock. Citadel Advisors LLC bought a new stake in shares of Movano Inc. (NASDAQ:MOVE) in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 49,262 shares of the technology company’s stock, valued at approximately $28,000. Citadel Advisors LLC owned 5.94% of Movano at the end of the most recent reporting period. Institutional investors own 16.64% of the company’s stock.

Movano Company Profile

Movano Health, Inc (NASDAQ: MOVE) is a health technology company focused on developing wearable devices for continuous biometric monitoring. The company’s core mission is to provide accessible, real-time health insights through noninvasive sensors, enabling individuals and care teams to track vital signs and physiological trends outside of traditional clinical settings.

Movano’s flagship product is a biometric monitoring ring designed to measure parameters such as heart rate, blood oxygen saturation, skin temperature, and sleep quality.